FDA Determines Regulatory Review Period for Nuflor Patent Extension

Summary

The Food and Drug Administration (FDA) has determined the regulatory review period for Nuflor, an animal drug product, and is publishing this notice as required by law. The FDA made this determination due to a submission to the Commissioner of Patents and Trademarks, Department of Commerce, for patent extension.